Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alkermes plc. Director's Dealing 2011

Sep 20, 2011

31048_dirs_2011-09-20_1b402491-7084-49b8-81dd-c310688d0d10.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2011-09-16

Reporting Person: FRATES JAMES M (SVP & CFO, Alkermes plc)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-09-16 Common Stock A 74606 Acquired 74606 Direct
2011-09-16 Common Stock A 4000 Acquired 4000 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-09-16 Non Qualified Stock Option (Right to Buy) $19.40 A 54845 Acquired 2011-10-02 Common Stock (54845) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $19.40 A 5155 Acquired 2011-10-02 Common Stock (5155) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $4.77 A 22296 Acquired 2012-07-18 Common Stock (22296) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $4.77 A 7504 Acquired 2012-07-18 Common Stock (7504) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $7.36 A 8726 Acquired 2012-12-12 Common Stock (8726) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $7.36 A 61274 Acquired 2012-12-12 Common Stock (61274) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $9.97 A 8750 Acquired 2013-04-25 Common Stock (8750) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $9.97 A 26250 Acquired 2013-04-25 Common Stock (26250) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $14.57 A 875 Acquired 2013-10-17 Common Stock (875) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.57 A 30625 Acquired 2013-10-17 Common Stock (30625) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $12.16 A 83499 Acquired 2013-12-10 Common Stock (83499) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $12.16 A 1 Acquired 2013-12-10 Common Stock (1) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $12.30 A 8130 Acquired 2014-07-12 Common Stock (8130) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $12.30 A 36870 Acquired 2014-07-12 Common Stock (36870) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.90 A 105000 Acquired 2014-12-17 Common Stock (105000) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $18.60 A 50874 Acquired 2015-12-09 Common Stock (50874) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $18.60 A 5376 Acquired 2015-12-09 Common Stock (5376) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $20.79 A 23315 Acquired 2016-05-02 Common Stock (23315) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $20.79 A 4810 Acquired 2016-05-02 Common Stock (4810) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.38 A 40000 Acquired 2016-12-12 Common Stock (40000) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $15.95 A 6269 Acquired 2017-06-01 Common Stock (6269) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $15.95 A 23731 Acquired 2017-06-01 Common Stock (23731) Direct
2011-09-16 Employee Stock Option (Right to Buy) $14.13 A 15000 Acquired 2017-11-05 Common Stock (15000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $12.29 A 50000 Acquired 2018-05-27 Common Stock (50000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $8.55 A 65000 Acquired 2019-05-26 Common Stock (65000) Direct
2011-09-16 Restricted Stock Award $0 A 4250 Acquired Common Stock (4250) Direct
2011-09-16 Employee Stock Option (Right to Buy) $9.21 A 50000 Acquired 2019-11-18 Common Stock (50000) Direct
2011-09-16 Restricted Stock Award $0 A 18750 Acquired Common Stock (18750) Direct
2011-09-16 Employee Stock Option (Right to Buy) $11.74 A 120500 Acquired 2020-05-17 Common Stock (120500) Direct
2011-09-16 Restricted Stock Unit Award $0 A 13050 Acquired Common Stock (13050) Direct

Footnotes

F1: Received in exchange for shares of Alkermes, Inc. common stock in connection with the merger of Alkermes, Inc. and the global drug delivery technologies business of Elan (the "Merger"). On 9/16/11, the effective date of the Merger, the closing price of ALKS was $16.57 per share.

F2: These options are fully vested in accordance with their terms.

F3: Received in exchange for, and having substantially the same terms as, stock options of Alkermes, Inc. common stock in connection with the Merger.

F4: 75% vested as of 9/16/11, remainder vests on 11/5/11.

F5: 75% vested as of 9/16/11, remainder vests on 5/27/12.

F6: 50% vested as of 9/16/11, remainder vests in 2 equal annual installments beginning on 5/26/12.

F7: Received in exchange for, and having substantially the same terms as, restricted stock unit awards of Alkermes, Inc. common stock in connection with the Merger.

F8: 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 11/18/11.

F9: 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 5/17/12.